EECP is the only safe and effective non-invasive treatment for patients with coronary heart disease.
EECP is a unique alternative for patients with coronary artery disease who are not candidates for angioplasty with stent (percutaneous coronary intervention) and/or bypass surgery (coronary artery bypass grafting surgery).
EECP is indicated for patients with symptomatic coronary artery disease despite optimal medical therapy or previous angioplasty and/or bypass surgery.
EECP should be offered as primary (initial) therapy for coronary heart disease patients with high risk and low benefit profiles, who are candidates for angioplasty or bypass surgery.
EECP is highly beneficial in those heart patients who have failed revascularization procedures (angioplasty or bypass surgery) or have decided not to have such procedures.
EECP is a low-cost and effective therapy with high patient acceptability as compared to angioplasty with stent or coronary bypass surgery.
Our state of art installation consists of:
Some of our EECP certified therapists have documented completion of more than 8,000 hours of EECP practical experience, in addition to continued medical and EECP education.
Chief Medical staff at local hospitals and directors of Invasive Cardiology Hemodynamics frequently refer patients to BPHC for EECP treatment.
Our EECP team is proudly led by Director Dr. Joe Caceres, who harnesses his more than 28 years of experience to provide patients with the highest standard of medical care and compassion. (Please see Biography ).
BPHC is proud to have organized and sponsored an EECP Symposium at the Marriott Suites Anaheim, with more such events planned in the future.
Dr. Rohit Arora, Chairman of Cardiology at The Chicago Medical School, discusses the role of EECP in the treatment of angina pectoris.
Dr. Rex Winters, Director of Invasive Cardiology at Long Beach Memorial Heart and Vascular Institute (LBMHVI), discusses the many benefits of EECP treatment at a BPHC-sponsored EECP symposium.